Cencora EBITDA 2010-2024 | COR

Cencora annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Cencora EBITDA for the quarter ending June 30, 2024 was $0.953B, a 0.66% increase year-over-year.
  • Cencora EBITDA for the twelve months ending June 30, 2024 was $3.648B, a 11.55% increase year-over-year.
  • Cencora 2023 annual EBITDA was $3.322B, a 5.21% increase from 2022.
  • Cencora 2022 annual EBITDA was $3.157B, a 8.84% increase from 2021.
  • Cencora 2021 annual EBITDA was $2.901B, a 166.44% decline from 2020.
Cencora Annual EBITDA
(Millions of US $)
2023 $3,322
2022 $3,157
2021 $2,901
2020 $-4,366
2019 $1,609
2018 $2,013
2017 $1,493
2016 $1,918
2015 $678
2014 $979
2013 $1,069
2012 $1,444
2011 $1,296
2010 $1,181
2009 $978
Cencora Quarterly EBITDA
(Millions of US $)
2024-06-30 $953
2024-03-31 $833
2023-12-31 $1,101
2023-09-30 $761
2023-06-30 $947
2023-03-31 $805
2022-12-31 $809
2022-09-30 $710
2022-06-30 $663
2022-03-31 $960
2021-12-31 $825
2021-09-30 $768
2021-06-30 $752
2021-03-31 $729
2020-12-31 $652
2020-09-30 $-5,652
2020-06-30 $504
2020-03-31 $410
2019-12-31 $373
2019-09-30 $293
2019-06-30 $519
2019-03-31 $184
2018-12-31 $613
2018-09-30 $341
2018-06-30 $535
2018-03-31 $607
2017-12-31 $531
2017-09-30 $-23
2017-06-30 $278
2017-03-31 $731
2016-12-31 $506
2016-09-30 $328
2016-06-30 $629
2016-03-31 $1,050
2015-12-31 $-89
2015-09-30 $620
2015-06-30 $403
2015-03-31 $-308
2014-12-31 $-37
2014-09-30 $266
2014-06-30 $160
2014-03-31 $347
2013-12-31 $205
2013-09-30 $158
2013-06-30 $178
2013-03-31 $392
2012-12-31 $341
2012-09-30 $361
2012-06-30 $361
2012-03-31 $409
2011-12-31 $313
2011-09-30 $245
2011-06-30 $349
2011-03-31 $396
2010-12-31 $307
2010-09-30 $250
2010-06-30 $308
2010-03-31 $336
2009-12-31 $288
2009-09-30 $250
2009-06-30 $237
2009-03-31 $271
Sector Industry Market Cap Revenue
Medical Medical Services $46.107B $262.173B
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00